SCHEMBL6348254

SCHEMBL6348254

CCOC(=O)c1cc(C)nn1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ENPP3 O14638 3/20 0.62
ALPL P05186 3/20 0.62
XIAP P98170 3/20 0.62
ELANE P08246 8/20 0.58
MAPT P10636 2/20 0.51
ENPP1 P22413 1/20 0.48
F2 P00734 2/20 0.47
PLAU P00749 1/20 0.47
KLKB1 P03952 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SIRT3 Q9NTG7 1/20 0.46
KMT2A Q03164 2/20 0.45
RAB9A P51151 2/20 0.45
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
GAA P10253 1/20 0.44
TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12204829 0.80 KDM4E (0.51) ENPP3ALPLXIAPELANEMAPT
Terevalefim SCHEMBL7169262 0.79 ELANE (0.42) ENPP3ALPLXIAPELANEMAPT
Terevalefim SCHEMBL7169259 0.79 ELANE (0.42) ENPP3ALPLXIAPELANEMAPT
SCHEMBL8511661 0.78 KMT2A (0.60) MAPTSMN1; SMN2MAPK1ALDH1A1KMT2A
SCHEMBL2336029 0.77 MAPT (0.59) MAPTSMN1; SMN2MAPK1KMT2ARAB9A
SCHEMBL15273732 0.77 SMN1; SMN2 (0.48) ELANEMAPTSMN1; SMN2MAPK1ALDH1A1
SCHEMBL25632856 0.73 SMN1; SMN2 (0.45) ELANESMN1; SMN2MAPK1ALDH1A1KMT2A
SCHEMBL203843 0.73 CA12 (0.68) MAPTSMN1; SMN2ALDH1A1SIRT3KMT2A
SCHEMBL1894879 0.70 LMNA (0.52) MAPTSMN1; SMN2ALDH1A1KMT2ARAB9A
SCHEMBL2071194 0.70 SMN1; SMN2 (0.57) MAPTSMN1; SMN2MAPK1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050096372-A1 Small-molecule modulators of hepatocyte growth factor/scatter factor activities PILLARISETTI SIVARAM (US) 2005-05-05 US disclosed
US-6855728-B2 Small-molecule modulators of hepatocyte growth factor / scatter factor activities NORTH SHORE-LONG ISLAND JEWISH HEALTH SYSTEM (US) 2005-02-15 US disclosed
US-20030216459-A1 Small-molecule modulators of hepatocyte growth factor / scatter factor activities THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216459-A1 Small-molecule modulators of hepatocyte growth factor / scatter factor activities HGF, HDGF, MET ENPP3 4055/4885ALPL 997/4885XIAP 1625/4885
US-20050096372-A1 Small-molecule modulators of hepatocyte growth factor/scatter factor activities HGF, HDGF, MET ENPP3 4055/4885ALPL 997/4885XIAP 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.